196 related articles for article (PubMed ID: 18397267)
1. Differential regulation of SOCS-1 signalling in B and T lymphocytes by hepatitis C virus core protein.
Yao ZQ; Prayther D; Trabue C; Dong ZP; Moorman J
Immunology; 2008 Oct; 125(2):197-207. PubMed ID: 18397267
[TBL] [Abstract][Full Text] [Related]
2. Abnormal B-cell activation associated with TALL-1 over-expression and SOCS-1 suppression during chronic hepatitis C virus infection.
Moorman J; Dong ZP; Ni L; Zhang C; Borthwick T; Yao ZQ
Immunology; 2009 Oct; 128(2):227-35. PubMed ID: 19740379
[TBL] [Abstract][Full Text] [Related]
3. Programmed death-1 affects suppressor of cytokine signaling-1 expression in T cells during hepatitis C infection.
Frazier AD; Zhang CL; Ni L; Ma CJ; Zhang Y; Wu XY; Atia AN; Yao ZQ; Moorman JP
Viral Immunol; 2010 Oct; 23(5):487-95. PubMed ID: 20883163
[TBL] [Abstract][Full Text] [Related]
4. Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.
Zhang Y; Ma CJ; Wang JM; Ji XJ; Wu XY; Jia ZS; Moorman JP; Yao ZQ
PLoS One; 2011; 6(5):e19664. PubMed ID: 21637332
[TBL] [Abstract][Full Text] [Related]
5. SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function.
Yao ZQ; Waggoner SN; Cruise MW; Hall C; Xie X; Oldach DW; Hahn YS
J Virol; 2005 Dec; 79(24):15417-29. PubMed ID: 16306613
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression.
Miyoshi H; Fujie H; Shintani Y; Tsutsumi T; Shinzawa S; Makuuchi M; Kokudo N; Matsuura Y; Suzuki T; Miyamura T; Moriya K; Koike K
J Hepatol; 2005 Nov; 43(5):757-63. PubMed ID: 16083990
[TBL] [Abstract][Full Text] [Related]
7. HCV core protein binds to gC1qR to induce A20 expression and inhibit cytokine production through MAPKs and NF-κB signaling pathways.
Song X; Yao Z; Yang J; Zhang Z; Deng Y; Li M; Ma C; Yang L; Gao X; Li W; Liu J; Wei L
Oncotarget; 2016 Jun; 7(23):33796-808. PubMed ID: 27183919
[TBL] [Abstract][Full Text] [Related]
8. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation.
Kittlesen DJ; Chianese-Bullock KA; Yao ZQ; Braciale TJ; Hahn YS
J Clin Invest; 2000 Nov; 106(10):1239-49. PubMed ID: 11086025
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of T and B lymphocytes by PD-1 and SOCS-1 signaling in hepatitis C virus-associated non-Hodgkin's lymphoma.
Yao ZQ; Ni L; Zhang Y; Ma CJ; Zhang CL; Dong ZP; Frazier AD; Wu XY; Thayer P; Borthwick T; Chen XY; Moorman JP
Immunol Invest; 2011; 40(3):243-64. PubMed ID: 21291295
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.
Ren JP; Zhao J; Dai J; Griffin JW; Wang L; Wu XY; Morrison ZD; Li GY; El Gazzar M; Ning SB; Moorman JP; Yao ZQ
Immunology; 2016 Aug; 148(4):377-86. PubMed ID: 27149428
[TBL] [Abstract][Full Text] [Related]
11. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk between programmed death-1 and suppressor of cytokine signaling-1 in inhibition of IL-12 production by monocytes/macrophages in hepatitis C virus infection.
Zhang Y; Ma CJ; Ni L; Zhang CL; Wu XY; Kumaraguru U; Li CF; Moorman JP; Yao ZQ
J Immunol; 2011 Mar; 186(5):3093-103. PubMed ID: 21263070
[TBL] [Abstract][Full Text] [Related]
13. Frequency of gC1qR+CD4+ T cells increases during acute hepatitis C virus infection and remains elevated in patients with chronic infection.
Cummings KL; Rosen HR; Hahn YS
Clin Immunol; 2009 Sep; 132(3):401-11. PubMed ID: 19473882
[TBL] [Abstract][Full Text] [Related]
14. T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
Yao ZQ; King E; Prayther D; Yin D; Moorman J
Viral Immunol; 2007; 20(2):276-87. PubMed ID: 17603844
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway.
Yao ZQ; Nguyen DT; Hiotellis AI; Hahn YS
J Immunol; 2001 Nov; 167(9):5264-72. PubMed ID: 11673541
[TBL] [Abstract][Full Text] [Related]
16. gC1qR expression in chimpanzees with resolved and chronic infection: potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection.
Yao ZQ; Shata MT; Tricoche N; Shan MM; Brotman B; Pfahler W; Hahn YS; Prince AM
Virology; 2006 Mar; 346(2):324-37. PubMed ID: 16368125
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus core protein reduces CD8
Khan ST; Karges W; Cooper CL; Crawley AM
Immunology; 2018 May; 154(1):156-165. PubMed ID: 29266204
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus: immunosuppression by complement regulatory pathway.
Yao ZQ; Ray S; Eisen-Vandervelde A; Waggoner S; Hahn YS
Viral Immunol; 2001; 14(4):277-95. PubMed ID: 11792059
[TBL] [Abstract][Full Text] [Related]
19. Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model.
Lukens JR; Cruise MW; Lassen MG; Hahn YS
J Immunol; 2008 Apr; 180(7):4875-84. PubMed ID: 18354211
[TBL] [Abstract][Full Text] [Related]
20. T-bet-mediated Tim-3 expression dampens monocyte function during chronic hepatitis C virus infection.
Yi W; Zhang P; Liang Y; Zhou Y; Shen H; Fan C; Moorman JP; Yao ZQ; Jia Z; Zhang Y
Immunology; 2017 Mar; 150(3):301-311. PubMed ID: 27809352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
